LDEBIO's AIMTB (Fluorescence Immunochromatography) Receives National Class III Medical Device Certification, Boosting Global TB Prevention and Control
Learn more+LDEBIO's AIMTB (Chemiluminescence Method) Secures National Class III Medical Device Certification, Completing Full-Platform, Full-Scenario TB Detection Solutions to Boost Global TB Control
Recently, the AIMTB Assay produced by Leide Biosciences Co., Ltd. has obtained registration certificates issued by NMPA, and will be officially commercialize in China domestic market
On August 19, 2019, LDEBIO received a B round of strategic investment from Kingmed capital with an amount of more than 50 million yuan.
RA_CP, an early RA ELISA diagnostic kit with a new international biomarker has been launched
Recently, a new international marker, rheumatoid arthritis citrullinated protein detection kit (RA_CP), innovatively developed by Leide Bioscience Co., Ltd. ("LDEBIO" for short) has obtained the National Medical Device Registration ...
Official WeChat Add：7D, Science & Technology Innovation Base, #80 Lanyue Road, Huangpu District, Guangzhou, P.R.China